SPP1 and intrahepatic cholangiocarcinoma: Indeed, a study on intrahepatic cholangiocarcinoma (ICC) revealed S100P and SPP1 as two potential biomarkers to study this tumour heterogeneity, with SPP1+ TAMs numerosity being particularly high in ICC peripheral small duct type compared to ICC perihilar large duct type [67].